Elizabeth Whittington

Newer targets found on cancer cells are providing scientists the ammunition to better treat cancer.

Occurring in up to 86 percent of chronic pain patients, breakthrough pain can be relieved by medication that acts within minutes for a short time.

Cancer that has spread to the bone can cause chronic pain, and many patients are undertreated for it. Now, pain specialists are addressing this problem and creating pain strategies specifically for metastatic cancer patients.

Renal cell carcinoma is the most common type of kidney cancer, comprising more than 90 percent of all kidney cancers.

ASCO fertility guidelines are still not yet widely followed.

A timeline for the development of awareness about cancer survivorship.

Women are being recruited for a different kind of army.

New drug therapies aid in the treatment of prostate cancer, glioblastoma, and renal cell carcinoma.

Dennis Slamon, MD, PhD, talks about his involvement in the history of Herceptin.

Herceptin can cause cardiac toxicity

Recent cancer research has been able to allow doctors to know what treatments work in certain patients—and what treatment don’t.

Adding Avastin to standard therapy delays progression of advanced HER2-negative breast cancer in women without prior treatment.

A large phase III study examining whether the addition of Tarceva (erlotinib) to Avastin (bevacizumab) delayed progression of advanced non-small cell lung cancer reached its primary goal.

Results from an international study challenge current practice of screening for ovarian cancer relapse.

Researchers of a follicular lymphoma trial hope that BiovaxID, a personalized vaccine, could help delay recurrences.

An international phase III trial found the investigational lung cancer drug, Zactima (vandetanib), significantly slowed the time a patient’s advanced lung cancer progressed.

Experts offer advice to survivors after a study shows people with cancer have a higher risk of being unemployed than people without a history of cancer.

A new organization aims to strike back at melanoma by developing the first-ever international melanoma tissue bank.

The 8th Annual Conference for Young Women Affected by Breast Cancer welcomed women diagnosed with breast cancer at 40 or younger.

FDA approves Mozobil for non-Hodgkin lymphoma and myeloma, and Degarelix for advanced prostate cancer.

Top insurance challenges facing cancer patients and how to get help.

Childhood cancer survivors skip needed mammograms

Patients call in for survivorship series teleconference

Connecting quality health care with economics